Karius
Medtech · Private
Liquid biopsy platform using next-generation sequencing to detect and identify pathogens from blood samples
kariusdx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $2.0M
- 16 awards · Defense, Veterans Affairs, Health and Human S
- #224 of 4531 in medtech
- Patents
- 40
- 12 granted · 28 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201920202021202220232024202520262027
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · Quantitative Next-generation Sequencing Test X 10 At $2,000 Each. | $20,000 | |
| Federal contract | Department of Defense · Quantitative Next Generation Sequencing Tests - 70EA | $140,000 | |
| Federal contract | Department of Defense · Quantitative Next-gen Sequencing Testing Services | $240,000 | |
| Federal contract | Department of Veterans Affairs · Karius Laboratory Tests For The Orlando Vamc. | $22,000 | |
| Federal contract | Department of Health and Human Services · Specialized Molecular Diagnostic Testing [22-011312] | $44,000 | |
| Federal contract | Department of Defense · Quantitative Next-gen Sequencing Testing Services | $250,000 | |
| Federal contract | Department of Veterans Affairs · Karius Next Generation Sequencing Test $2,000.00 Per Test | $60,000 | |
| Federal contract | Department of Health and Human Services · Karius, INC.:1354298 [23-009483] | $80,000 | |
| Federal contract | Department of Defense · Quantiative Next-gen Sequencing Test | $98,000 | |
| Federal contract | Department of Health and Human Services · Karius, Inc. R&d For Metagenomic Sequencing Of Microbial Cell-free Dna And Rna For Comprehensive Pathogen Detection Aoi #26 Agnostic Diagnostic | $630,976 | |
| Federal contract | Department of Veterans Affairs · Karius Next Generation Sequencing Test Delivery (2D Opt, 3RD Yr) | $46,000 | |
| Federal contract | Department of Veterans Affairs · 36C25725D0031 - Order # 36C25725N0219 | $22,000 | |
| Federal contract | Department of Veterans Affairs · Karius Next Generation Sequencing Test $2,000.00 Per Test | $120,000 | |
| Federal contract | Department of Health and Human Services · Procurement Of Molecular Diagnostic Testing | $74,800 | |
| Federal contract | Department of Veterans Affairs · Karius Next Generation Sequencing Test | $22,000 | |
| Federal contract | Department of Veterans Affairs · Karius Next Generation Sequencing Test $2,000.00 Per Test | $120,000 |
Federal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 221 | NEURONEXUS TECHNOLOGIES | $2.0M | — |
| 222 | JUXTOPIA, LLC | $2.0M | — |
| 223 | TransMedics | $2.0M | $155M |
| 224 | Karius | $2.0M | — |
| 225 | CSA Medical, Inc. | $2.0M | $157M |
| 226 | VISTENDO INC | $1.9M | — |
| 227 | PURIOLABS, LLC | $1.9M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Sample Processing To Enrich For Select Species Of Nucleic Acidsapplication
- Direct-to-library Methods, Systems, And Compositionsgranted
- Synthetic Nucleic Acid Spike-insgranted
- Compositions And Methods For Enriching Populations Of Nucleic Acidsapplication
- Direct-to-library Methods, Systems, And Compositionsgranted
- Compositions And Methods For Enriching Populations Of Nucleic Acidsgranted
- Synthetic Nucleic Acid Spike-insapplication
- Sample Series To Differentiate Target Nucleic Acids From Contaminant Nucleic Acidsapplication
- Reduction Of Signal From Contaminant Nucleic Acidsapplication
- Microbial Biomarkers In Transplantation And Related Methodsapplication
- Sample Preparation Methods, Systems And Compositionsapplication
- Rapid, Non-invasive Detection And Serial Monitoring Of Infections In Subjects Using Microbial Cell-free Dna Sequencingapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.